Get startedLog in
    Picture of BioArctic AB logo

    BIOA B — BioArctic AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapHigh Flyer
    All News

    Brief: BioArctic's Leqembi Approved For Treatment Of Alzheimer's Disease In China

    Picture of BioArctic AB logoBioArctic AB
    09/01/2024 08:33
    Jan 9 (Reuters) - BioArctic AB  BIOAb.ST :
    * LEQEMBI® APPROVED FOR THE TREATMENT OF ALZHEIMER'S DISEASE
IN
CHINA
    * EISAI ANNOUNCED THAT LEQEMBI HAS BEEN APPROVED IN CHINA AS
REATMENT FOR MILD COGNITIVE IMPAIRMENT AND MILD AD DEMENTIA
    * EISAI'S PREPARATIONS FOR CHINESE LAUNCH IN OF Q3 2024 ARE
UNDERWAY

Source text for Eikon:  ID:nWkr1MfjQS 
Further company coverage:  BIOAb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on BioArctic AB

    See all news